Growth Opportunities for Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening

Growth Opportunities for Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening

Artificial Intelligence and Deep Learning Support Better Clinical Outcomes and Fuel Growth Pipeline

RELEASE DATE
07-Feb-2022
REGION
North America
Deliverable Type
Market Research
Research Code: PC50-01-00-00-00
SKU: HC03499-NA-MT_26241
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03499-NA-MT_26241

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due to their use as a primary tool for breast cancer detection. These segments are followed by MRI-CAD, which is mainly used as an adjunct to both mammography and ultrasound in breast imaging.

Analysis of the competitive landscape indicates that the top companies accounted for a combined 95% of the total CAD in breast cancer screening market for 2021. Offering AI-enabled CAD solutions is a growth area observed in the market. Given the market dynamics, trends, and competitive nature, it is important for industry stakeholders to have an overall perspective of the technology segments and workflow. This report offers insightful analysis of CAD in breast cancer screening in the form of a global forecast, regional and technological forecasts and analyses, benchmarking of top competitors, and key growth opportunities for industry participants.

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening Market

Growth Opportunities Fuel the Growth Pipeline Engine™

Main Highlights

CAD in Breast Cancer Screening Scope of Analysis

Market Overview

Market Segmentation by Technology

Key Competitors by Region for CAD in Breast Cancer Screening

Key Growth Metrics for CAD in Breast Cancer Screening

Growth Drivers for CAD in Breast Cancer Screening

Growth Restraints for CAD in Breast Cancer Screening

Forecast Methodology and Assumptions

Revenue Forecast

Global Revenue Forecast Analysis

Revenue Forecast by Segment

Mammo-CAD Revenue Forecast

Mammo-CAD—Revenue Forecast Analysis

Ultrasound-CAD Revenue Forecast

Ultrasound CAD—Revenue Forecast Analysis

PET/CT-CAD Revenue Forecast

PET/CT-CAD—Revenue Forecast Analysis

MRI-CAD Revenue Forecast

MRI-CAD—Revenue Forecast Analysis

Revenue Forecast by Region

Revenue Forecast Analysis by Region

Pricing Trends Forecast by Product, CAD in Breast Cancer Screening

Pricing Trends and Forecast Analysis

Competitive Environment

Adoption Curve of CAD in Breast Cancer Screening by Product Type

Top Competitor—Hologic

Top Competitor—iCAD

Revenue Share

Revenue Share Analysis

Business Model Overview—CAD in Breast Cancer Screening

Clinical End-user Perspective

Factors to Consider for Seamless Integration with Workflow—CAD in Breast Cancer Screening Market

Key Growth Metrics for CAD in Breast Cancer Screening Market, North America

CAD in Breast Cancer Screening Market Dynamics, North America

Revenue Forecast, North America

Percent Revenue by Segment, North America

Revenue Forecast by Segment Analysis, North America

Revenue Forecast by Segment Discussion, North America (continued)

Competitive Environment, North America

Competitive Environment Analysis, North America

Key Growth Metrics for CAD in Breast Cancer Screening Market, Europe

CAD in Breast Cancer Screening Market Dynamics, Europe

Revenue Forecast, Europe

Percent Revenue by Segment, Europe

Revenue Forecast by Segment Analysis, Europe

Revenue Forecast by Segment Analysis, Europe (continued)

Competitive Environment, Europe

Competitive Environment Analysis, Europe

Key Growth Metrics for CAD in Breast Cancer Screening Market, APAC

CAD in Breast Cancer Screening Market Dynamics, APAC

Revenue Forecast, APAC

Percent Revenue by Segment, APAC

Revenue Forecast by Segment Analysis, APAC

Revenue Forecast by Segment Analysis, APAC (continued)

Competitive Environment, APAC

Competitive Environment Analysis, APAC

Key Growth Metrics for CAD in Breast Cancer Screening Market, ROW

CAD in Breast Cancer Screening Market Dynamics, ROW

Revenue Forecast, ROW

Percent Revenue by Segment, ROW

Revenue Forecast by Segment Analysis, ROW

Revenue Forecast by Segment Analysis, ROW (continued)

Competitive Environment, ROW

Competitive Environment Analysis, ROW

Growth Opportunity Summary

Growth Opportunity 1—Opportunities with Breast Cancer Screening Using Mobile Mammography and Mobile Ultrasound

Growth Opportunity 1—Opportunities with Breast Cancer Screening Using Mobile Mammography and Mobile Ultrasound (continued)

Growth Opportunity 2—AI Coupled with DL to Support Better Clinical Outcomes in Breast Cancer Screening

Growth Opportunity 2—AI Coupled with DL to Support Better Clinical Outcomes in Breast Cancer Screening (continued)

Growth Opportunity 3—Utilizing CAD Triage (CADt) to Reduce Human Error and Increase Efficiency in Breast Imaging

Growth Opportunity 3—Utilizing CAD Triage (CADt) to Reduce Human Error and Increase Efficiency in Breast Imaging (continued)

Growth Opportunity 4—Partnerships with OEMs Providing Breast Screening Systems to Gain a Wider Customer Base

Growth Opportunity 4—Partnerships with OEMs Providing Breast Screening Systems to Gain a Wider Customer Base (continued)

Growth Opportunity 5—Increase in Use of CAD in APAC to Bolster Clinical Adoption in the Region

Growth Opportunity 5—Increase in Use of CAD in APAC to Bolster Clinical Adoption in the Region (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

Legal Disclaimer

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due to their use as a primary tool for breast cancer detection. These segments are followed by MRI-CAD, which is mainly used as an adjunct to both mammography and ultrasound in breast imaging. Analysis of the competitive landscape indicates that the top companies accounted for a combined 95% of the total CAD in breast cancer screening market for 2021. Offering AI-enabled CAD solutions is a growth area observed in the market. Given the market dynamics, trends, and competitive nature, it is important for industry stakeholders to have an overall perspective of the technology segments and workflow. This report offers insightful analysis of CAD in breast cancer screening in the form of a global forecast, regional and technological forecasts and analyses, benchmarking of top competitors, and key growth opportunities for industry participants.
More Information
Deliverable Type Market Research
Author Anannya Sinha
GPS Codes 9600-B1,9825-B1,9A06-B1,9566-B1,9570-B1,99CC-B1,99BE-B1,9614-B1
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Computer Aided Diagnosis
Keyword 2 computer aided diagnosis in medical imaging
Keyword 3 CAD for Breast Cancer Screening
Podcast No
WIP Number PC50-01-00-00-00